Leucine-rich repeat kinase 2 inhibitors: a patent review (2014-present)
Cited by 35
Related Papers
AlphaFold accelerates artificial intelligence powered drug discovery: efficient discovery of a novel CDK20 small molecule inhibitor
|Chemical Science|2023|322
A small-molecule TNIK inhibitor targets fibrosis in preclinical and clinical models
|Nature Biotechnology|2024|265
Chemistry42: An AI-Driven Platform for Molecular Design and Optimization
|Journal of Chemical Information and Modeling|2023|196
PandaOmics: An AI-Driven Platform for Therapeutic Target and Biomarker Discovery
|Journal of Chemical Information and Modeling|2024|125
Identification of Therapeutic Targets for Amyotrophic Lateral Sclerosis Using PandaOmics – An AI-Enabled Biological Target Discovery Platform
|Frontiers in Aging Neuroscience|2022|99